In a panel discussion, Columbia faculty share insights into how precision medicine can be applied to the treatment of psychiatric disorders.
A new study shows patients who do not improve with a standard antipsychotic have better outcomes if they switch to clozapine.
A new study of deaths in people with schizophrenia shows that more needs to be done to improve the physical health of adults with schizophrenia.
A new Mailman study examines the separate effects of clinical symptoms and labeling on stigma in young people identified as at risk for psychotic disorders.
Deborah Hasin finds that marijuana use has doubled in the United States, and with the increase comes more marijuana use disorders and cannabis-related accidents.
When first-line OCD drug treatment is not enough, Columbia and NYSPI research shows that cognitive behavioral therapy should be added.